Asset Details
Do you wish to reserve the book?
Kidney Function in Patients With Adrenal Adenomas: A Single-Center Retrospective Cohort Study
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Kidney Function in Patients With Adrenal Adenomas: A Single-Center Retrospective Cohort Study
Do you wish to request the book?
Kidney Function in Patients With Adrenal Adenomas: A Single-Center Retrospective Cohort Study
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Kidney Function in Patients With Adrenal Adenomas: A Single-Center Retrospective Cohort Study
2024
Overview
Abstract
Context
Patients with nonfunctioning adrenal adenomas (NFA) and mild autonomous cortisol secretion (MACS) demonstrate an increased risk of chronic kidney disease (CKD); however, factors associated with CKD are unknown.
Objective
We aimed to identify the factors associated with CKD and assess the effect of adrenalectomy on kidney function in patients with NFA or MACS.
Methods
A single-center cohort study of patients with NFA and MACS, 1999 to 2020, was conducted. MACS was diagnosed based on post dexamethasone suppression test (DST) cortisol greater than or equal to 1.8 mcg/dL. Age, sex, dysglycemia, hypertension, therapy with statin, angiotensin-converting enzyme inhibitor, or angiotensin II receptor blocker were included in the multivariable analysis. Outcomes included estimated glomerular filtration rate (eGFR) at the time of diagnosis with MACS or NFA and postadrenalectomy delta eGFR.
Results
Of 972 patients, 429 (44%) had MACS and 543 (56%) had NFA. At the time of diagnosis, patients with MACS had lower eGFR (median 79.6 vs 83.8 mL/min/1.73 m2; P < .001) than patients with NFA. In a multivariable analysis, factors associated with lower eGFR were older age, hypertension, and higher DST. In 204 patients (MACS: 155, 76% and NFA: 49, 24%) treated with adrenalectomy, postadrenalectomy eGFR improved in both groups starting at 18 months up to 3.5 years of follow-up. Factors associated with increased eGFR were younger age, lower preadrenalectomy eGFR, and longer follow-up period.
Conclusion
DST cortisol is an independent risk factor for lower eGFR in patients with adrenal adenomas. Patients with both MACS and NFA demonstrate an increase in eGFR post adrenalectomy, especially younger patients with lower eGFR pre adrenalectomy.
Publisher
Oxford University Press
Subject
/ Adrenal Gland Neoplasms - surgery
/ Adrenocortical Adenoma - complications
/ Adrenocortical Adenoma - surgery
/ Adult
/ Aged
/ Angiotensin-converting enzyme inhibitors
/ Clinical
/ Cortisol
/ Enzymes
/ Epidermal growth factor receptors
/ Female
/ Glomerular Filtration Rate - physiology
/ Hormones
/ Humans
/ Male
/ Renal Insufficiency, Chronic - physiopathology
/ Statins
/ Tumors
